| 1 | Structure-activity relationship and target investigation of 2-aryl quinolines with nematocidal activity | 3.1 | 9 | Citations (PDF) |
| 2 | In Vitro Antischistosomal Activity of Bridelia ferruginea, Clausena anisata, Khaya senegalensis, and Vernonia amygdalina | 2.2 | 0 | Citations (PDF) |
| 3 | Egg excretion patterns of soil-transmitted helminth infections in humans following albendazole-ivermectin and albendazole treatment | 3.1 | 4 | Citations (PDF) |
| 4 | Analysis of the Physicochemical Properties of Anti-Schistosomal Compounds to Identify Next-Generation Leads | 3.4 | 7 | Citations (PDF) |
| 5 | Robenidine derivatives as potential antischistosomal drug candidates | 3.1 | 0 | Citations (PDF) |
| 6 | Understanding Drug Exposure and Trichuris trichiura Cure Rates: A Pharmacometric Approach for Albendazole-Ivermectin Co-medication in Tanzania and Côte d’Ivoire | 1.9 | 1 | Citations (PDF) |
| 7 | A novel barcoded nanopore sequencing workflow of high-quality, full-length bacterial 16S amplicons for taxonomic annotation of bacterial isolates and complex microbial communities | 4.5 | 5 | Citations (PDF) |
| 8 | <i>In Vitro</i> and <i>In Vivo</i> Antischistosomal Activity Profiling and Pharmacokinetics of Ozonide Carboxylic Acids | 3.7 | 4 | Citations (PDF) |
| 9 | Ivermectin and moxidectin against soil-transmitted helminth infections | 3.2 | 19 | Citations (PDF) |
| 10 | Correlation of Cytokines with Parasitic Infections, Undernutrition and Micronutrient Deficiency among Schoolchildren in Rural Tanzania: A Cross-Sectional Study | 4.7 | 9 | Citations (PDF) |
| 11 | Development of a hookworm egg hatching assay to determine the ovicidal effects of anthelminthics | 3.2 | 5 | Citations (PDF) |
| 12 | Emodepside for
<i>Trichuris trichiura</i>
and Hookworm Infection | 43.7 | 35 | Citations (PDF) |
| 13 | Bridged 1,2,4-Trioxolanes: SnCl4—Catalyzed Synthesis and an In Vitro Study against S. mansoni | 4.3 | 6 | Citations (PDF) |
| 14 | Efficacy and Safety of Moxidectin-Albendazole and Ivermectin-Albendazole Combination Therapy Compared to Albendazole Monotherapy in Adolescents and Adults Infected with <i>Trichuris trichiura</i>: A Randomized, Controlled Superiority Trial | 5.4 | 20 | Citations (PDF) |
| 15 | Design, Synthesis and Evaluation of Praziquantel Analogues and New Molecular Hybrids as Potential Antimalarial and Anti-Schistosomal Agents | 4.3 | 3 | Citations (PDF) |
| 16 | Trichuris muris egg-hatching assay for anthelminthic drug discovery and characterization | 3.1 | 6 | Citations (PDF) |
| 17 | Discovery of novel antischistosomal scaffolds from the open access Pandemic Response Box | 4.0 | 14 | Citations (PDF) |
| 18 | Efficacy and safety of co-administered ivermectin and albendazole in school-aged children and adults infected with Trichuris trichiura in Côte d'Ivoire, Laos, and Pemba Island, Tanzania: a double-blind, parallel-group, phase 3, randomised controlled trial | 15.7 | 67 | Citations (PDF) |
| 19 | Improving anthelmintic treatment for schistosomiasis and soil-transmitted helminthiases through sharing and reuse of individual participant data | 1.0 | 6 | Citations (PDF) |
| 20 | Pharmacokinetic modelling and simulation to optimize albendazole dosing in hookworm- or <i>Trichuris trichiura-</i>infected infants to adults | 3.2 | 3 | Citations (PDF) |
| 21 | R-praziquantel integrated population pharmacokinetics in preschool- and school-aged African children infected with Schistosoma mansoni and S. haematobium and Lao adults infected with Opisthorchis viverrini | 2.1 | 4 | Citations (PDF) |
| 22 | Antischistosomal tetrahydro-γ-carboline sulfonamides | 2.1 | 4 | Citations (PDF) |
| 23 | Different gut microbial communities correlate with efficacy of albendazole-ivermectin against soil-transmitted helminthiases | 13.9 | 33 | Citations (PDF) |
| 24 | G-quadruplexes in helminth parasites | 15.7 | 18 | Citations (PDF) |
| 25 | Malnutrition, anemia, micronutrient deficiency and parasitic infections among schoolchildren in rural Tanzania | 3.1 | 23 | Citations (PDF) |
| 26 | Real-time and automated monitoring of antischistosomal drug activity profiles for screening of compound libraries | 3.6 | 1 | Citations (PDF) |
| 27 | Whole-organism phenotypic screening methods used in early-phase anthelmintic drug discovery | 11.9 | 42 | Citations (PDF) |
| 28 | Optimizing moxidectin dosing for <i>Strongyloides stercoralis</i> infections: Insights from pharmacometric modeling | 2.8 | 14 | Citations (PDF) |
| 29 | In vitro antischistosomal activity of Artemisia annua and Artemisia afra extracts | 2.5 | 13 | Citations (PDF) |
| 30 | Visible Light‐driven Metal‐free C–H Functionalization: Access to New Bioactive Tetrahydroisoquinoline‐Butenolide Hybrids via Domino Amine Oxidation/Vinylogous Mannich Reaction | 2.6 | 1 | Citations (PDF) |
| 31 | Albatrellus confluens (Alb. & Schwein.) Kotl. & Pouz.: Natural Fungal Compounds and Synthetic Derivatives with In Vitro Anthelmintic Activities and Antiproliferative Effects against Two Human Cancer Cell Lines | 4.3 | 12 | Citations (PDF) |
| 32 | Development of Praziquantel sulphonamide derivatives as antischistosomal drugs | 5.2 | 9 | Citations (PDF) |
| 33 | Effects of Structurally Different HDAC Inhibitors against <i>Trypanosoma cruzi</i>, <i>Leishmania</i>, and <i>Schistosoma mansoni</i> | 3.7 | 22 | Citations (PDF) |
| 34 | Optimizing Implementation of Preventive Chemotherapy against Soil-Transmitted Helminthiasis and Intestinal Schistosomiasis Using High-Resolution Data: Field-Based Experiences from Côte d’Ivoire | 2.8 | 2 | Citations (PDF) |
| 35 | Modeling the effect of different drugs and treatment regimen for hookworm on cure and egg reduction rates taking into account diagnostic error | 3.1 | 7 | Citations (PDF) |
| 36 | Medicinal Plant Preparations Administered by Botswana Traditional Health Practitioners for Treatment of Worm Infections Show Anthelmintic Activities | 3.8 | 9 | Citations (PDF) |
| 37 | Efficacy and Safety of Albendazole in Hookworm-infected Preschool-aged Children, School-aged Children, and Adults in Côte d’Ivoire: A Phase 2 Randomized, Controlled Dose-finding Trial | 5.4 | 11 | Citations (PDF) |
| 38 | A cross-sectional survey on parasitic infections in schoolchildren in a rural Tanzanian community | 2.3 | 7 | Citations (PDF) |
| 39 | Expanding the Activity Profile of Pyrido[1,2-<i>a</i>]benzimidazoles: Synthesis and Evaluation of Novel <i>N</i><sup>1</sup>-1-Phenylethanamine Derivatives against <i>Schistosoma mansoni</i> | 3.7 | 14 | Citations (PDF) |
| 40 | Characterization of Moxidectin against <i>Strongyloides ratti</i>: In Vitro and In Vivo Activity and Pharmacokinetics in the Rat Model | 3.7 | 12 | Citations (PDF) |
| 41 | Activities of Quinoxaline, Nitroquinoxaline, and [1,2,4]Triazolo[4,3-a]quinoxaline Analogs of MMV007204 against Schistosoma mansoni | 4.2 | 11 | Citations (PDF) |
| 42 | Evaluation of Commercially Available Anthelminthics in Laboratory Models of Human Intestinal Nematode Infections | 3.7 | 15 | Citations (PDF) |
| 43 | Optimization of Benzothiazole and Thiazole Hydrazones as Inhibitors of Schistosome BCL-2 | 3.7 | 4 | Citations (PDF) |
| 44 | Assessment of fecal calprotectin and fecal occult blood as point-of-care markers for soil-transmitted helminth attributable intestinal morbidity in a case-control substudy conducted in Côte d'Ivoire, Lao PDR and Pemba Island, Tanzania | 8.5 | 5 | Citations (PDF) |
| 45 | A systematic review and an individual patient data meta-analysis of ivermectin use in children weighing less than fifteen kilograms: Is it time to reconsider the current contraindication? | 3.1 | 61 | Citations (PDF) |
| 46 | Validation of a human-serum-based in vitro growth method for drug screening on juvenile development stages of Schistosoma mansoni | 3.1 | 14 | Citations (PDF) |
| 47 | Development and validation of an LC-MS/MS method for the quantification of the anthelmintic drug moxidectin in a volumetric absorptive microsample, blood, and plasma: Application to a pharmacokinetic study of adults infected with Strongyloides stercoralis in Laos | 2.6 | 14 | Citations (PDF) |
| 48 | Structural Requirements for Dihydrobenzoxazepinone Anthelmintics: Actions against Medically Important and Model Parasites: <i>Trichuris muris</i>, <i>Brugia malayi</i>, <i>Heligmosomoides polygyrus</i>, and <i>Schistosoma mansoni</i> | 3.7 | 18 | Citations (PDF) |
| 49 | Preclinical and Clinical Characteristics of the Trichuricidal Drug Oxantel Pamoate and Clinical Development Plans: A Review | 11.8 | 15 | Citations (PDF) |
| 50 | Evaluation of two communication tools, slideshow and theater, to improve participants’ understanding of a clinical trial in the informed consent procedure on Pemba Island, Tanzania | 3.1 | 3 | Citations (PDF) |
| 51 | Long-term outcomes of ivermectin-albendazole versus albendazole alone against soil-transmitted helminths: Results from randomized controlled trials in Lao PDR and Pemba Island, Tanzania | 3.1 | 28 | Citations (PDF) |
| 52 | Efficacy and safety of moxidectin and albendazole compared to ivermectin and albendazole co-administration in adolescents infected with Trichuris trichiura: a randomized controlled trial protocol | 0.7 | 0 | Citations (PDF) |
| 53 | Development of emodepside as a possible adulticidal treatment for human onchocerciasis—The fruit of a successful industrial–academic collaboration | 4.4 | 40 | Citations (PDF) |
| 54 | Characterization of the Population Pharmacokinetics of Moxidectin in Adults Infected with Strongyloides Stercoralis: Support for a Fixed-Dose Treatment Regimen | 3.6 | 7 | Citations (PDF) |
| 55 | Efficacy and safety of ascending doses of moxidectin against Strongyloides stercoralis infections in adults: a randomised, parallel-group, single-blinded, placebo-controlled, dose-ranging, phase 2a trial | 15.7 | 38 | Citations (PDF) |
| 56 | Efficacy and safety of moxidectin and albendazole compared to ivermectin and albendazole co-administration in adolescents infected with Trichuris trichiura: a randomized controlled trial protocol | 0.7 | 4 | Citations (PDF) |
| 57 | <i>In Vitro</i>
,
<i>In Vivo</i>
, and Absorption, Distribution, Metabolism, and Excretion Evaluation of SF
<sub>5</sub>
-Containing
<i>N,N’</i>
-Diarylureas as Antischistosomal Agents | 4.2 | 9 | Citations (PDF) |
| 58 | Diagnosis of soil-transmitted helminths using the Kato-Katz technique: What is the influence of stirring, storage time and storage temperature on stool sample egg counts? | 3.1 | 55 | Citations (PDF) |
| 59 | Identification of Adult Fasciola spp. Using Matrix-Assisted Laser/Desorption Ionization Time-of-Flight (MALDI-TOF) Mass Spectrometry | 3.9 | 18 | Citations (PDF) |
| 60 | Individual responses to a single oral dose of albendazole indicate reduced efficacy against soil-transmitted helminths in an area with high drug pressure | 3.1 | 24 | Citations (PDF) |
| 61 | Population Pharmacokinetics and Exposure-Response Analysis of Tribendimidine To Improve Treatment for Children with Hookworm Infection | 4.2 | 2 | Citations (PDF) |
| 62 | Pharmacometric Analysis of Tribendimidine Monotherapy and Combination Therapies To Achieve High Cure Rates in Patients with Hookworm Infections | 4.2 | 3 | Citations (PDF) |
| 63 | Anthelmintic Activity and Cytotoxic Effects of Compounds Isolated from the Fruits of Ozoroa insignis Del. (Anacardiaceae) | 4.4 | 10 | Citations (PDF) |
| 64 | In Vitro Antileishmanial and Antischistosomal Activities of Anemonin Isolated from the Fresh Leaves of Ranunculus multifidus Forsk | 4.3 | 10 | Citations (PDF) |
| 65 | Assessment of FDA-approved drugs against Strongyloides ratti in vitro and in vivo to identify potentially active drugs against strongyloidiasis | 3.2 | 9 | Citations (PDF) |
| 66 | Efficacy and Safety of Ascending Dosages of Moxidectin and Moxidectin-albendazole Against Trichuris trichiura in Adolescents: A Randomized Controlled Trial | 5.4 | 27 | Citations (PDF) |
| 67 | Informed consent procedure in a double blind randomized anthelminthic trial on Pemba Island, Tanzania: do pamphlet and information session increase caregivers knowledge? | 2.6 | 54 | Citations (PDF) |
| 68 | Study of drug particle distributions within mini-tablets using synchrotron X-ray microtomography and superpixel image clustering | 4.8 | 14 | Citations (PDF) |
| 69 | An in-depth report of quality control on Kato-Katz and data entry in four clinical trials evaluating the efficacy of albendazole against soil-transmitted helminth infections | 3.1 | 7 | Citations (PDF) |
| 70 | Comparison of real-time PCR and the Kato-Katz method for the diagnosis of soil-transmitted helminthiasis and assessment of cure in a randomized controlled trial | 3.9 | 33 | Citations (PDF) |
| 71 | Evaluation of Human Liver Microtissues for Drug Screening on Schistosoma mansoni Schistosomula | 3.7 | 1 | Citations (PDF) |
| 72 | Efficacy, safety and acceptability of a new chewable formulation versus the solid tablet of mebendazole against hookworm infections in children: An open-label, randomized controlled trial | 8.5 | 17 | Citations (PDF) |
| 73 | Multidisciplinary Preclinical Investigations on Three Oxamniquine Analogues as New Drug Candidates for Schistosomiasis** | 3.4 | 6 | Citations (PDF) |
| 74 | Performance of the Kato-Katz method and real time polymerase chain reaction for the diagnosis of soil-transmitted helminthiasis in the framework of a randomised controlled trial: treatment efficacy and day-to-day variation | 3.2 | 39 | Citations (PDF) |
| 75 | Naturally Occurring Cardenolides Affecting <i>Schistosoma mansoni</i> | 3.7 | 6 | Citations (PDF) |
| 76 | Whipworm and roundworm infections | 50.7 | 225 | Citations (PDF) |
| 77 | Parallelized Impedance‐Based Platform for Continuous Dose‐Response Characterization of Antischistosomal Drugs | 3.5 | 10 | Citations (PDF) |
| 78 | Efficacy and safety of single-dose 40 mg/kg oral praziquantel in the treatment of schistosomiasis in preschool-age versus school-age children: An individual participant data meta-analysis | 3.1 | 14 | Citations (PDF) |
| 79 | Efficacy and safety of ascending dosages of albendazole against Trichuris trichiura in preschool-aged children, school-aged children and adults: A multi-cohort randomized controlled trial | 8.5 | 26 | Citations (PDF) |
| 80 | Mechanochemical Formation of Racemic Praziquantel Hemihydrate with Improved Biopharmaceutical Properties | 5.1 | 28 | Citations (PDF) |
| 81 | Structure–Activity Relationship of Antischistosomal Ozonide Carboxylic Acids | 5.6 | 25 | Citations (PDF) |
| 82 | Efficacy, metabolism and pharmacokinetics of Ro 15-5458, a forgotten schistosomicidal 9-acridanone hydrazone | 3.2 | 6 | Citations (PDF) |
| 83 | Identifying thresholds for classifying moderate-to-heavy soil-transmitted helminth intensity infections for FECPAKG2, McMaster, Mini-FLOTAC and qPCR | 3.1 | 23 | Citations (PDF) |
| 84 | Preparation, Physicochemical Characterization and In Vitro and In Vivo Activity Against Heligmosomoides polygyrus of Novel Oral Formulations of Albendazole and Mebendazole | 3.2 | 11 | Citations (PDF) |
| 85 | Synthesis, characterization and antiparasitic activity of organometallic derivatives of the anthelmintic drug albendazole | 3.0 | 19 | Citations (PDF) |
| 86 | One mean to rule them all? The arithmetic mean based egg reduction rate can be misleading when estimating anthelminthic drug efficacy in clinical trials | 3.1 | 18 | Citations (PDF) |
| 87 | Piloting a surveillance system to monitor the global patterns of drug efficacy and the emergence of anthelmintic resistance in soil-transmitted helminth control programs: a Starworms study protocol | 0.7 | 20 | Citations (PDF) |
| 88 | Antischistosomal, antionchocercal and antitrypanosomal potentials of some Ghanaian traditional medicines and their constituents | 3.1 | 13 | Citations (PDF) |
| 89 | Diagnostic performance of a single and duplicate Kato-Katz, Mini-FLOTAC, FECPAKG2 and qPCR for the detection and quantification of soil-transmitted helminths in three endemic countries | 3.1 | 98 | Citations (PDF) |
| 90 | Therapeutic efficacy of albendazole against soil-transmitted helminthiasis in children measured by five diagnostic methods | 3.1 | 48 | Citations (PDF) |
| 91 | Clinical evaluation for morbidity associated with soil-transmitted helminth infection in school-age children on Pemba Island, Tanzania | 3.1 | 7 | Citations (PDF) |
| 92 | Activity and pharmacokinetics of a praziquantel crystalline polymorph in the Schistosoma mansoni mouse model | 4.1 | 21 | Citations (PDF) |
| 93 | Exploring mechanochemical parameters using a DoE approach: Crystal structure solution from synchrotron XRPD and characterization of a new praziquantel polymorph | 4.4 | 28 | Citations (PDF) |
| 94 | Exogenous Iron Increases Fasciocidal Activity and Hepatocellular Toxicity of the Synthetic Endoperoxides OZ78 and MT04 | 4.5 | 12 | Citations (PDF) |
| 95 | Reply to Nalin | 5.4 | 0 | Citations (PDF) |
| 96 | Evaluation of emodepside in laboratory models of human intestinal nematode and schistosome infections | 3.2 | 27 | Citations (PDF) |
| 97 | Ivermectin Dosing Strategy to Achieve Equivalent Exposure Coverage in Children and Adults | 4.9 | 20 | Citations (PDF) |
| 98 | Combining Mechanochemistry and Spray Congealing for New Praziquantel Pediatric Formulations in Schistosomiasis Treatment | 4.5 | 11 | Citations (PDF) |
| 99 | Novel 1-Methyl-1<i>H</i>-pyrazole-5-carboxamide Derivatives with Potent Anthelmintic Activity | 5.6 | 23 | Citations (PDF) |
| 100 | Pharmacokinetics of ascending doses of ivermectin in Trichuris trichiura-infected children aged 2–12 years | 3.2 | 38 | Citations (PDF) |
| 101 | Pooled Population Pharmacokinetic Analysis of Tribendimidine for the Treatment of
<i>Opisthorchis viverrini</i>
Infections | 4.2 | 6 | Citations (PDF) |
| 102 | Pharmacokinetics of Albendazole, Albendazole Sulfoxide, and Albendazole Sulfone Determined from Plasma, Blood, Dried-Blood Spots, and Mitra Samples of Hookworm-Infected Adolescents | 4.2 | 32 | Citations (PDF) |
| 103 | Multi-center screening of the Pathogen Box collection for schistosomiasis drug discovery | 3.2 | 26 | Citations (PDF) |
| 104 | Structure–Activity Relationship and <i>in Vitro</i> Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) Studies of <i>N</i>-aryl 3-Trifluoromethyl Pyrido[1,2-<i>a</i>]benzimidazoles That Are Efficacious in a Mouse Model of Schistosomiasis | 3.7 | 17 | Citations (PDF) |
| 105 | Structure–Activity Relationship Studies of Tolfenpyrad Reveal Subnanomolar Inhibitors of <i>Haemonchus contortus</i> Development | 5.6 | 22 | Citations (PDF) |
| 106 | Early Antischistosomal Leads Identified from <i>in Vitro</i> and <i>in Vivo</i> Screening of the Medicines for Malaria Venture Pathogen Box | 3.7 | 27 | Citations (PDF) |
| 107 | <i>In Vitro</i>
and
<i>In Vivo</i>
Drug-Drug Interaction Study of the Effects of Ivermectin and Oxantel Pamoate on Tribendimidine | 4.2 | 10 | Citations (PDF) |
| 108 | Efficacy and Safety of Ascending Dosages of Tribendimidine Against Hookworm Infections in Children: A Randomized Controlled Trial | 5.4 | 7 | Citations (PDF) |
| 109 | Efficacy and tolerability of triple drug therapy with albendazole, pyrantel pamoate, and oxantel pamoate compared with albendazole plus oxantel pamoate, pyrantel pamoate plus oxantel pamoate, and mebendazole plus pyrantel pamoate and oxantel pamoate against hookworm infections in school-aged children in Laos: a randomised, single-blind trial | 15.7 | 27 | Citations (PDF) |
| 110 | Efficacy and Safety of Ivermectin Against Trichuris trichiura in Preschool-aged and School-aged Children: A Randomized Controlled Dose-finding Trial | 5.4 | 44 | Citations (PDF) |
| 111 | Evaluation of a novel micro-sampling device, Mitra™, in comparison to dried blood spots, for analysis of praziquantel in Schistosoma haematobium-infected children in rural Côte d’Ivoire | 3.1 | 28 | Citations (PDF) |
| 112 | Evaluation of Two DNA Extraction Methods for Detection of Strongyloides stercoralis Infection | 4.1 | 13 | Citations (PDF) |
| 113 | A new soluble and bioactive polymorph of praziquantel | 4.1 | 57 | Citations (PDF) |
| 114 | Retrospective assessment of resource use and costs in two investigator-initiated randomized trials exemplified a comprehensive cost item list | 3.7 | 21 | Citations (PDF) |
| 115 | Progress in antischistosomal N,N′-diaryl urea SAR | 2.1 | 19 | Citations (PDF) |
| 116 | The optimal timing of post-treatment sampling for the assessment of anthelminthic drug efficacy against Ascaris infections in humans | 3.1 | 27 | Citations (PDF) |
| 117 | Characterizing the Biochemical Response to <i>Schistosoma mansoni</i> Infection and Treatment with Praziquantel in Preschool and School Aged Children | 3.5 | 5 | Citations (PDF) |
| 118 | Efficacy and safety of tribendimidine versus praziquantel against Opisthorchis viverrini in Laos: an open-label, randomised, non-inferiority, phase 2 trial | 15.7 | 31 | Citations (PDF) |
| 119 | Modification and optimization of the FECPAKG2 protocol for the detection and quantification of soil-transmitted helminth eggs in human stool | 3.1 | 22 | Citations (PDF) |
| 120 | Synthesis, characterization and biological activity of organometallic derivatives of the antimalarial drug mefloquine as new antischistosomal drug candidates | 4.6 | 15 | Citations (PDF) |
| 121 | Optimization of Novel 1-Methyl-1<i>H</i>-Pyrazole-5-carboxamides Leads to High Potency Larval Development Inhibitors of the Barber’s Pole Worm | 5.6 | 36 | Citations (PDF) |
| 122 | Impedance-Based Microfluidic Assay for Automated Antischistosomal Drug Screening | 8.5 | 27 | Citations (PDF) |
| 123 | Assessment of tegumental damage to Schistosoma mansoni and S. haematobium after in vitro exposure to ferrocenyl, ruthenocenyl and benzyl derivatives of oxamniquine using scanning electron microscopy | 3.2 | 20 | Citations (PDF) |
| 124 | Extrapolation of praziquantel pharmacokinetics to a pediatric population: a cautionary tale | 2.1 | 23 | Citations (PDF) |
| 125 | SAR of a new antischistosomal urea carboxylic acid | 2.1 | 5 | Citations (PDF) |
| 126 | Comprehensive evaluation of stool-based diagnostic methods and benzimidazole resistance markers to assess drug efficacy and detect the emergence of anthelmintic resistance: A Starworms study protocol | 3.1 | 36 | Citations (PDF) |
| 127 | Effects of Vancomycin and Ciprofloxacin on the NMRI Mouse Metabolism | 3.5 | 10 | Citations (PDF) |
| 128 | Efficacy and tolerability of moxidectin alone and in co-administration with albendazole and tribendimidine versus albendazole plus oxantel pamoate against Trichuris trichiura infections: a randomised, non-inferiority, single-blind trial | 15.7 | 39 | Citations (PDF) |
| 129 | Pharmacokinetics of a Pediatric Tribendimidine Dose-Finding Study To Treat Hookworm Infection in African Children | 4.2 | 5 | Citations (PDF) |
| 130 | Development and validation of a LC-MS/MS method for ivermectin quantification in dried blood spots: application to a pharmacokinetic study in<i>Trichuris trichiura</i>-infected adults | 2.6 | 21 | Citations (PDF) |
| 131 | Acting beyond 2020: better characterization of praziquantel and promising antischistosomal leads | 4.0 | 18 | Citations (PDF) |
| 132 | Screening a repurposing library, the Medicines for Malaria Venture Stasis Box, against Schistosoma mansoni | 3.2 | 25 | Citations (PDF) |
| 133 | Diagnostic comparison between FECPAKG2 and the Kato-Katz method for analyzing soil-transmitted helminth eggs in stool | 3.1 | 40 | Citations (PDF) |
| 134 | A Rapid Appraisal of Factors Influencing Praziquantel Treatment Compliance in Two Communities Endemic for Schistosomiasis in Côte d’Ivoire | 2.3 | 23 | Citations (PDF) |
| 135 | Off-target effects of tribendimidine, tribendimidine plus ivermectin, tribendimidine plus oxantel-pamoate, and albendazole plus oxantel-pamoate on the human gut microbiota | 3.1 | 24 | Citations (PDF) |
| 136 | Investigations on the interplays between Schistosoma mansoni, praziquantel and the gut microbiome | 3.2 | 94 | Citations (PDF) |
| 137 | Toward the 2020 goal of soil-transmitted helminthiasis control and elimination | 3.1 | 84 | Citations (PDF) |
| 138 | Efficacy and Safety of a Single Dose versus a Multiple Dose Regimen of Mebendazole against Hookworm Infections in Children: A Randomised, Double-blind Trial | 8.5 | 33 | Citations (PDF) |
| 139 | Efficacy and safety of ascending doses of praziquantel against Schistosoma haematobium infection in preschool-aged and school-aged children: a single-blind randomised controlled trial | 7.5 | 22 | Citations (PDF) |
| 140 | Preventive Chemotherapy in the Fight against Soil-Transmitted Helminthiasis: Achievements and Limitations | 3.2 | 57 | Citations (PDF) |
| 141 | Efficacy and safety of co-administered ivermectin plus albendazole for treating soil-transmitted helminths: A systematic review, meta-analysis and individual patient data analysis | 3.1 | 104 | Citations (PDF) |
| 142 | Pharmacokinetics of Praziquantel in Schistosoma mansoni- and Schistosoma haematobium-Infected School- and Preschool-Aged Children | 4.2 | 21 | Citations (PDF) |
| 143 | Efficacy and safety of praziquantel against light infections of
<i>Opisthorchis viverrini</i>
: a randomised parallel single blind dose-ranging trial | 5.4 | 26 | Citations (PDF) |
| 144 | Treatment of human and livestock helminth infections in a mobile pastoralist setting at Lake Chad: Attitudes to health and analysis of active pharmaceutical ingredients of locally available anthelminthic drugs | 2.3 | 12 | Citations (PDF) |
| 145 | Poor Validity of Noninvasive Hemoglobin Measurements by Pulse Oximetry Compared with Conventional Absorptiometry in Children in Côte d'Ivoire | 0.0 | 2 | Citations (PDF) |
| 146 | Controlling schistosomiasis with praziquantel: How much longer without a viable alternative? | 4.8 | 175 | Citations (PDF) |
| 147 | Exposure of Heligmosomoides polygyrus and Trichuris muris to albendazole, albendazole sulfoxide, mebendazole and oxantel pamoate in vitro and in vivo to elucidate the pathway of drug entry into these gastrointestinal nematodes | 3.1 | 19 | Citations (PDF) |
| 148 | Antischistosomal Activity of Pyrido[1,2-<i>a</i>]benzimidazole Derivatives and Correlation with Inhibition of β-Hematin Formation | 3.7 | 20 | Citations (PDF) |
| 149 | Efficacy and safety of praziquantel in preschool-aged and school-aged children infected with Schistosoma mansoni: a randomised controlled, parallel-group, dose-ranging, phase 2 trial | 14.0 | 70 | Citations (PDF) |
| 150 | Screening of the ‘Open Scaffolds’ collection from Compounds Australia identifies a new chemical entity with anthelmintic activities against different developmental stages of the barber's pole worm and other parasitic nematodes | 3.1 | 37 | Citations (PDF) |
| 151 | An explorative analysis of process and formulation variables affecting comilling in a vibrational mill: The case of praziquantel | 4.8 | 30 | Citations (PDF) |
| 152 | Excretory/secretory products from the gastrointestinal nematode Trichuris muris | 1.4 | 62 | Citations (PDF) |
| 153 | Efficacy of Moxidectin Versus Ivermectin Against Strongyloides stercoralis Infections: A Randomized, Controlled Noninferiority Trial | 5.4 | 49 | Citations (PDF) |
| 154 | Immunohistochemical Investigations of Treatment with Ro 13-3978, Praziquantel, Oxamniquine, and Mefloquine in Schistosoma mansoni-Infected Mice | 4.2 | 18 | Citations (PDF) |
| 155 | Efficacy and safety of tribendimidine, tribendimidine plus ivermectin, tribendimidine plus oxantel pamoate, and albendazole plus oxantel pamoate against hookworm and concomitant soil-transmitted helminth infections in Tanzania and Côte d'Ivoire: a randomised, controlled, single-blinded, non-inferiority trial | 15.7 | 44 | Citations (PDF) |
| 156 | Ferrocenyl, Ruthenocenyl, and Benzyl Oxamniquine Derivatives with Cross-Species Activity against <i>Schistosoma mansoni</i> and <i>Schistosoma haematobium</i> | 3.7 | 36 | Citations (PDF) |
| 157 | In vitro and in vivo activity of R- and S- praziquantel enantiomers and the main human metabolite trans-4-hydroxy-praziquantel against Schistosoma haematobium | 3.2 | 52 | Citations (PDF) |
| 158 | Ultrasonographic evaluation of urinary tract morbidity in school-aged and preschool-aged children infected with Schistosoma haematobium and its evolution after praziquantel treatment: A randomized controlled trial | 3.1 | 33 | Citations (PDF) |
| 159 | Mobile-phone and handheld microscopy for neglected tropical diseases | 3.1 | 25 | Citations (PDF) |
| 160 | Evaluation of the pharmacokinetic-pharmacodynamic relationship of praziquantel in the Schistosoma mansoni mouse model | 3.1 | 43 | Citations (PDF) |
| 161 | Side Benefits of Mass Drug Administration for Lymphatic Filariasis on Strongyloides stercoralis Prevalence on Pemba Island, Tanzania | 0.0 | 20 | Citations (PDF) |
| 162 | Open Source Drug Discovery with the Malaria Box Compound Collection for Neglected Diseases and Beyond | 4.4 | 263 | Citations (PDF) |
| 163 | Pharmacokinetic Study of Praziquantel Enantiomers and Its Main Metabolite R-trans-4-OH-PZQ in Plasma, Blood and Dried Blood Spots in Opisthorchis viverrini-Infected Patients | 3.1 | 20 | Citations (PDF) |
| 164 | Accuracy of Mobile Phone and Handheld Light Microscopy for the Diagnosis of Schistosomiasis and Intestinal Protozoa Infections in Côte d’Ivoire | 3.1 | 54 | Citations (PDF) |
| 165 | Evaluation of a Urine Pooling Strategy for the Rapid and Cost-Efficient Prevalence Classification of Schistosomiasis | 3.1 | 13 | Citations (PDF) |
| 166 | StrongNet: An International Network to Improve Diagnostics and Access to Treatment for Strongyloidiasis Control | 3.1 | 33 | Citations (PDF) |
| 167 | Bimodal X‐ray and Infrared Imaging of an Organometallic Derivative of Praziquantel in <i>Schistosoma mansoni</i> | 2.6 | 18 | Citations (PDF) |
| 168 | Single-Ascending-Dose Pharmacokinetic Study of Tribendimidine in Opisthorchis viverrini-Infected Patients | 4.2 | 9 | Citations (PDF) |
| 169 | Evaluation of an FDA approved library against laboratory models of human intestinal nematode infections | 3.2 | 40 | Citations (PDF) |
| 170 | Comparison of sensitivity and faecal egg counts of Mini-FLOTAC using fixed stool samples and Kato-Katz technique for the diagnosis of Schistosoma mansoni and soil-transmitted helminths | 2.3 | 24 | Citations (PDF) |
| 171 | Pharmacokinetics of the Antischistosomal Lead Ozonide OZ418 in Uninfected Mice Determined by Liquid Chromatography-Tandem Mass Spectrometry | 4.2 | 8 | Citations (PDF) |
| 172 | Efficacy and safety of tribendimidine against Opisthorchis viverrini : two randomised, parallel-group, single-blind, dose-ranging, phase 2 trials | 15.7 | 26 | Citations (PDF) |
| 173 | <i>In Vitro</i>
and
<i>In Vivo</i>
Drug Interaction Study of Two Lead Combinations, Oxantel Pamoate plus Albendazole and Albendazole plus Mebendazole, for the Treatment of Soil-Transmitted Helminthiasis | 4.2 | 12 | Citations (PDF) |
| 174 | Approved oncology drugs lack in vivo activity against Trichuris muris despite in vitro activity | 1.8 | 6 | Citations (PDF) |
| 175 | Revisiting the SAR of the Antischistosomal Aryl Hydantoin (Ro 13-3978) | 5.6 | 29 | Citations (PDF) |
| 176 | Evaluation of Malaria Diagnoses Using a Handheld Light Microscope in a Community-Based Setting in Rural Côte d'Ivoire | 0.0 | 21 | Citations (PDF) |
| 177 | Re-infection with Fasciola gigantica 6-month post-treatment with triclabendazole in cattle from mobile pastoralist husbandry systems at Lake Chad | 2.0 | 5 | Citations (PDF) |
| 178 | Population Pharmacokinetic Modeling of Tribendimidine Metabolites in Opisthorchis viverrini-Infected Adults | 4.2 | 9 | Citations (PDF) |
| 179 | Efficacy and reinfection with soil-transmitted helminths 18-weeks post-treatment with albendazole-ivermectin, albendazole-mebendazole, albendazole-oxantel pamoate and mebendazole | 3.2 | 55 | Citations (PDF) |
| 180 | Discovery of Antischistosomal Drug Leads Based on Tetraazamacrocyclic Derivatives and Their Metal Complexes | 4.2 | 28 | Citations (PDF) |
| 181 | Development and validation of an enantioselective LC–MS/MS method for the analysis of the anthelmintic drug praziquantel and its main metabolite in human plasma, blood and dried blood spots | 3.1 | 30 | Citations (PDF) |
| 182 | Clonorchiasis | 52.8 | 312 | Citations (PDF) |
| 183 | Effect of sanitation and water treatment on intestinal protozoa infection: a systematic review and meta-analysis | 15.7 | 145 | Citations (PDF) |
| 184 | Efficacy and safety of oxantel pamoate in school-aged children infected with Trichuris trichiura on Pemba Island, Tanzania: a parallel, randomised, controlled, dose-ranging study | 15.7 | 53 | Citations (PDF) |
| 185 | Efficacy and Safety of Moxidectin, Synriam, Synriam-Praziquantel versus Praziquantel against Schistosoma haematobium and S. mansoni Infections: A Randomized, Exploratory Phase 2 Trial | 3.1 | 27 | Citations (PDF) |
| 186 | Human Trichuriasis: Diagnostics Update | 1.6 | 17 | Citations (PDF) |
| 187 | Fluorescence/luminescence-based markers for the assessment of Schistosoma mansoni schistosomula drug assays | 3.2 | 41 | Citations (PDF) |
| 188 | LC–MS/MS method for the determination of two metabolites of tribendimidine, deacylated amidantel and its acetylated metabolite in plasma, blood and dried blood spots | 3.1 | 10 | Citations (PDF) |
| 189 | Repurposing of anticancer drugs: in vitro and in vivo activities against Schistosoma mansoni | 3.2 | 64 | Citations (PDF) |
| 190 | Bacteria-induced egg hatching differs for Trichuris muris and Trichuris suis | 3.2 | 32 | Citations (PDF) |
| 191 | Elucidation of the in vitro and in vivo activities of bridged 1,2,4-trioxolanes, bridged 1,2,4,5-tetraoxanes, tricyclic monoperoxides, silyl peroxides, and hydroxylamine derivatives against Schistosoma mansoni | 2.6 | 49 | Citations (PDF) |
| 192 | Efficacy and safety of albendazole plus ivermectin, albendazole plus mebendazole, albendazole plus oxantel pamoate, and mebendazole alone against Trichuris trichiura and concomitant soil-transmitted helminth infections: a four-arm, randomised controlled trial | 15.7 | 121 | Citations (PDF) |
| 193 | Quality control in the diagnosis of Trichuris trichiura and Ascaris lumbricoides using the Kato-Katz technique: experience from three randomised controlled trials | 3.2 | 72 | Citations (PDF) |
| 194 | Activities of
<i>N</i>
,
<i>N</i>
′-Diarylurea MMV665852 Analogs against Schistosoma mansoni | 4.2 | 33 | Citations (PDF) |
| 195 | Toward Measuring Schistosoma Response to Praziquantel Treatment with Appropriate Descriptors of Egg Excretion | 3.1 | 30 | Citations (PDF) |
| 196 | Opisthorchiasis: An Overlooked Danger | 3.1 | 43 | Citations (PDF) |
| 197 | How Long Can Stool Samples Be Fixed for an Accurate Diagnosis of Soil-Transmitted Helminth Infection Using Mini-FLOTAC? | 3.1 | 29 | Citations (PDF) |
| 198 | Diagnosis of Schistosoma haematobium Infection with a Mobile Phone-Mounted Foldscope and a Reversed-Lens CellScope in Ghana | 0.0 | 79 | Citations (PDF) |
| 199 | Aryl hydantoin Ro 13-3978, a broad-spectrum antischistosomal | 3.2 | 20 | Citations (PDF) |
| 200 | Toward Organometallic Antischistosomal Drug Candidates | 2.4 | 40 | Citations (PDF) |
| 201 | A novel isothermal microcalorimetry tool to assess drug effects on Ancylostoma ceylanicum and Necator americanus | 4.1 | 7 | Citations (PDF) |
| 202 | Activity Profile of an FDA-Approved Compound Library against Schistosoma mansoni | 3.1 | 68 | Citations (PDF) |
| 203 | Orally Active Antischistosomal Early Leads Identified from the Open Access Malaria Box | 3.1 | 79 | Citations (PDF) |
| 204 | Praziquantel, Mefloquine-Praziquantel, and Mefloquine-Artesunate-Praziquantel against Schistosoma haematobium: A Randomized, Exploratory, Open-Label Trial | 3.1 | 51 | Citations (PDF) |
| 205 | Characterization of the Ca2+-Gated and Voltage-Dependent K+-Channel Slo-1 of Nematodes and Its Interaction with Emodepside | 3.1 | 51 | Citations (PDF) |
| 206 | Quantitative Evaluation of a Handheld Light Microscope for Field Diagnosis of Soil-Transmitted Helminth Infection | 0.0 | 15 | Citations (PDF) |
| 207 | Oxantel Pamoate–Albendazole for<i>Trichuris trichiura</i>Infection | 43.7 | 99 | Citations (PDF) |
| 208 | Antischistosomal versus Antiandrogenic Properties of Aryl Hydantoin Ro 13-3978 | 0.0 | 10 | Citations (PDF) |
| 209 | Amino ozonides exhibit in vitro activity against Echinococcus multilocularis metacestodes | 4.0 | 42 | Citations (PDF) |
| 210 | The little we know about the pharmacokinetics and pharmacodynamics of praziquantel (racemate and R-enantiomer) | 3.2 | 147 | Citations (PDF) |
| 211 | Repurposing drugs for the treatment and control of helminth infections | 3.1 | 176 | Citations (PDF) |
| 212 | Synthesis and activity of new triphenylphosphonium derivatives of betulin and betulinic acid against Schistosoma mansoni in vitro and in vivo | 2.6 | 50 | Citations (PDF) |
| 213 | Synthesis and Biological Evaluation of Organoruthenium Complexes with Azole Antifungal Agents. First Crystal Structure of a Tioconazole Metal Complex | 2.9 | 59 | Citations (PDF) |
| 214 | Activity of Praziquantel Enantiomers and Main Metabolites against Schistosoma mansoni | 4.2 | 97 | Citations (PDF) |
| 215 | Evaluation of portable microscopic devices for the diagnosis of <i>Schistosoma</i> and soil-transmitted helminth infection | 1.8 | 39 | Citations (PDF) |
| 216 | Development of an in vitro drug sensitivity assay for Trichuris muris first-stage larvae | 3.2 | 30 | Citations (PDF) |
| 217 | Advances with the Chinese anthelminthic drug tribendimidine in clinical trials and laboratory investigations | 2.3 | 67 | Citations (PDF) |
| 218 | Isothermal microcalorimetry to study the activity of triclabendazole and its metabolites on juvenile and adult Fasciola hepatica | 1.4 | 13 | Citations (PDF) |
| 219 | [(η<sup>6</sup>‐Praziquantel)Cr(CO)<sub>3</sub>] Derivatives with Remarkable In Vitro Anti‐schistosomal Activity | 3.4 | 39 | Citations (PDF) |
| 220 | In Vitro Metabolic Profile and in Vivo Antischistosomal Activity Studies of (η<sup>6</sup>-Praziquantel)Cr(CO)<sub>3</sub> Derivatives | 5.6 | 44 | Citations (PDF) |
| 221 | Activity of Oxantel Pamoate Monotherapy and Combination Chemotherapy against Trichuris muris and Hookworms: Revival of an Old Drug | 3.1 | 40 | Citations (PDF) |
| 222 | Low Efficacy of Single-Dose Albendazole and Mebendazole against Hookworm and Effect on Concomitant Helminth Infection in Lao PDR | 3.1 | 129 | Citations (PDF) |
| 223 | Efficacy and Safety of Praziquantel in Preschool-Aged Children in an Area Co-Endemic for Schistosoma mansoni and S. haematobium | 3.1 | 79 | Citations (PDF) |
| 224 | Antischistosomal Activities of Mefloquine-Related Arylmethanols | 4.2 | 51 | Citations (PDF) |
| 225 | Characterization of Constituents and Anthelmintic Properties of Hagenia abyssinica | 2.3 | 37 | Citations (PDF) |
| 226 | Effect of Sanitation on Soil-Transmitted Helminth Infection: Systematic Review and Meta-Analysis | 8.5 | 466 | Citations (PDF) |
| 227 | Global burden of human food-borne trematodiasis: a systematic review and meta-analysis | 15.7 | 512 | Citations (PDF) |
| 228 | Nitazoxanide: In vitro and in vivo drug effects against Trichuris muris and Ancylostoma ceylanicum, alone or in combination | 3.1 | 19 | Citations (PDF) |
| 229 | Pharmacokinetics of the fasciocidal drug candidates MT04 and OZ78 in uninfected rats and in vitro pharmacodynamic studies | 3.1 | 8 | Citations (PDF) |
| 230 | In vitro and in vivo efficacy of tribendimidine and its metabolites alone and in combination against the hookworms Heligmosomoides bakeri and Ancylostoma ceylanicum | 2.3 | 34 | Citations (PDF) |
| 231 | Ferrocenyl Derivatives of the Anthelmintic Praziquantel: Design, Synthesis, and Biological Evaluation | 5.6 | 70 | Citations (PDF) |
| 232 | Effect of combinations of marketed human anthelmintic drugs against Trichuris muris in vitro and in vivo | 3.2 | 41 | Citations (PDF) |
| 233 | Identification of Antischistosomal Leads by Evaluating Bridged 1,2,4,5-Tetraoxanes, Alphaperoxides, and Tricyclic Monoperoxides | 5.6 | 82 | Citations (PDF) |
| 234 | Anthelminthic properties of mangostin and mangostin diacetate | 1.7 | 24 | Citations (PDF) |
| 235 | Mefloquine interferes with glycolysis in schistosomula of <i>Schistosoma mansoni</i> via inhibition of enolase | 1.8 | 34 | Citations (PDF) |
| 236 | Antiparasitic drugs for paediatrics: systematic review, formulations, pharmacokinetics, safety, efficacy and implications for control | 1.8 | 40 | Citations (PDF) |
| 237 | Interactions of mefloquine with praziquantel in the Schistosoma mansoni mouse model and in vitro | 3.2 | 65 | Citations (PDF) |
| 238 | Isothermal Microcalorimetry To Study Drugs against Schistosoma mansoni | 4.1 | 60 | Citations (PDF) |
| 239 | Efficacy and safety of mefloquine, artesunate, mefloquine–artesunate, tribendimidine, and praziquantel in patients with Opisthorchis viverrini: a randomised, exploratory, open-label, phase 2 trial | 15.7 | 79 | Citations (PDF) |
| 240 | Potential Drug Development Candidates for Human Soil-Transmitted Helminthiases | 3.1 | 86 | Citations (PDF) |
| 241 | Efficacy of the cyclooctadepsipeptide PF1022A against<i>Heligmosomoides bakeri in vitro</i>and<i>in vivo</i> | 1.8 | 7 | Citations (PDF) |
| 242 | Schistosoma mansoni: Antischistosomal activity of the four optical isomers and the two racemates of mefloquine on schistosomula and adult worms in vitro and in vivo | 1.4 | 45 | Citations (PDF) |
| 243 | Efficacy and Safety of Artemether in the Treatment of Chronic Fascioliasis in Egypt: Exploratory Phase-2 Trials | 3.1 | 40 | Citations (PDF) |
| 244 | In Vitro and In Vivo Efficacy of Monepantel (AAD 1566) against Laboratory Models of Human Intestinal Nematode Infections | 3.1 | 66 | Citations (PDF) |
| 245 | Efficacy, safety and pharmacokinetics of 1,2,4-trioxolane OZ78 against an experimental infection with Fasciola hepatica in sheep | 2.0 | 20 | Citations (PDF) |
| 246 | Praziquantel analogs with activity against juvenile Schistosoma mansoni | 2.1 | 57 | Citations (PDF) |
| 247 | Activity of Artemether and Mefloquine against Juvenile and Adult Schistosoma mansoni in Athymic and Immunocompetent NMRI Mice | 0.0 | 23 | Citations (PDF) |
| 248 | Activity of antiandrogens against juvenile and adult Schistosoma mansoni in mice | 3.2 | 26 | Citations (PDF) |
| 249 | Efficacy and Safety of Mefloquine, Artesunate, Mefloquine‐Artesunate, and Praziquantel against<i>Schistosoma haematobium</i>: Randomized, Exploratory Open‐Label Trial | 5.4 | 141 | Citations (PDF) |
| 250 | Effect of artemether, artesunate, OZ78, praziquantel, and tribendimidine alone or in combination chemotherapy on the tegument of Clonorchis sinensis | 1.7 | 18 | Citations (PDF) |
| 251 | Anthelmintic activity of artesunate against Fasciola hepatica in naturally infected sheep | 1.8 | 52 | Citations (PDF) |
| 252 | Combination Chemotherapy against
Clonorchis sinensis
: Experiments with Artemether, Artesunate, OZ78, Praziquantel, and Tribendimidine in a Rat Model | 4.2 | 23 | Citations (PDF) |
| 253 | Mefloquine—An Aminoalcohol with Promising Antischistosomal Properties in Mice | 3.1 | 182 | Citations (PDF) |
| 254 | Metabolic profiling of a Schistosoma mansoni infection in mouse tissues using magic angle spinning-nuclear magnetic resonance spectroscopy | 2.9 | 68 | Citations (PDF) |
| 255 | Dose-response relationships and tegumental surface alterations in Opisthorchis viverrini following treatment with mefloquine in vivo and in vitro | 1.8 | 24 | Citations (PDF) |
| 256 | Food-Borne Trematodiases | 17.4 | 581 | Citations (PDF) |
| 257 | Opisthorchis viverrini: efficacy and tegumental alterations following administration of tribendimidine in vivo and in vitro | 1.8 | 17 | Citations (PDF) |
| 258 | Efficacy and safety of artemether against a natural Fasciola hepatica infection in sheep | 1.8 | 55 | Citations (PDF) |
| 259 | Fasciola hepatica: Surface tegumental responses to in vitro and in vivo treatment with the experimental fasciolicide OZ78 | 1.4 | 17 | Citations (PDF) |
| 260 | Efficacy of Current Drugs Against Soil-Transmitted Helminth Infections | 17.1 | 750 | Citations (PDF) |
| 261 | Strongyloides ratti: In Vitro and In Vivo Activity of Tribendimidine | 3.1 | 29 | Citations (PDF) |
| 262 | In Vitro and In Vivo Activities of Synthetic Trioxolanes against Major Human Schistosome Species | 4.2 | 172 | Citations (PDF) |
| 263 | Artemisinins and synthetic trioxolanes in the treatment of helminth infections | 3.5 | 128 | Citations (PDF) |
| 264 | Activity of artemether and OZ78 against triclabendazole-resistant Fasciola hepatica | 1.4 | 49 | Citations (PDF) |
| 265 | Food-borne trematodiasis: current chemotherapy and advances with artemisinins and synthetic trioxolanes | 3.2 | 113 | Citations (PDF) |
| 266 | Schistosomiasis and water resources development: systematic review, meta-analysis, and estimates of people at risk | 15.7 | 1,930 | Citations (PDF) |
| 267 | Trends in the core literature on tropical medicine: a bibliometric analysis from 1952-2002 | 2.6 | 49 | Citations (PDF) |
| 268 | Reducing the burden of malaria in different eco-epidemiological settings with environmental management: a systematic review | 15.7 | 223 | Citations (PDF) |
| 269 | Investigations of the metabolites of the trypanocidal drug melarsoprol | 4.9 | 48 | Citations (PDF) |
| 270 | Efficacy of recommended drugs against soil transmitted helminths: systematic review and network meta-analysis | 0.1 | 276 | Citations (PDF) |
| 271 | Pharmacokinetics of Ascending Doses of Praziquantel in Adults Infected with Opisthorchis felineus in Western Siberia, Russian Federation | 4.2 | 4 | Citations (PDF) |
